The extracellular matrix - the under-recognized element in lung disease?

Area of Science:

• Pulmonary Medicine
• Cellular Biology
• Biochemistry

Background:

• The lung's extracellular matrix (ECM) provides structural support to airways and parenchyma.
• Historically viewed as inert, the ECM is now recognized as a bioactive regulator of cellular responses.
• ECM alterations are implicated in the pathology of major respiratory diseases.

Purpose of the Study:

• To review current knowledge on ECM alterations in asthma, COPD, and IPF.
• To explore the contribution of ECM changes to respiratory disease pathologies.
• To identify potential therapeutic strategies targeting ECM modifications.

Main Methods:

• Literature review of studies investigating ECM in lung diseases.
• Synthesis of research on ECM composition, structure, and function in respiratory pathologies.
• Analysis of emerging data on ECM-cell interactions in disease.

Main Results:

• ECM alterations are integral to the pathological profiles of asthma, COPD, and IPF.
• Changes in ECM composition, folding, or rigidity significantly impact cellular functions.
• These ECM modifications actively contribute to disease progression and pathological outcomes.

Conclusions:

• The lung ECM is a dynamic, bioactive component crucial to respiratory health and disease.
• ECM alterations are not merely consequences but drivers of chronic lung disease pathology.
• Targeting ECM modifications presents a promising avenue for novel therapeutic interventions in lung diseases.